AbbVie Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 300 Posts
1 2 3 ... 19
June 2019 Stock Considerations
Article By: Keith Park Wednesday, June 12, 2019 4:10 AM EDT
After a wild May, we seem to be trending back up in June.
In this article: MO, PM, GILD, ABBV
Read
E AbbVie: This High-Yield Dividend Aristocrat Is A Buy
Article By: SureDividend Monday, June 10, 2019 8:03 PM EDT
AbbVie stock has significantly underperformed the broader S&P Index this year, but the stock could be a bargain and an attractive buying opportunity for long-term dividend growth.
In this article: ABBV
Read
E Portfolio Highlights - June 2019
Article By: Ingrid Hendershot Wednesday, June 5, 2019 3:13 PM EDT
During the past three months, the S&P 500 Index rose 2.6% despite renewed concerns over a trade war. The following high-quality stocks all generated double-digit gains during the same period.
In this article: FDS, FB, MSFT, PAYX, MA, CSCO, PEP, ABBV, ROST, WBA, FFIV, GNTX, GPC, MMS
Read
Dividend Income Update May 2019
Article By: Andreas Gruener Sunday, June 2, 2019 9:13 PM EDT
Time for one of my favorite posts of each month: the dividend income update. It is now already June, one of the strongest dividend months of the year. But May was not so for us either...
In this article: PG, VZ, T, ABBV, GIS, HRL, BASFY, DDAIF, MURGY, VE
Read
Is AbbVie Stock A Buy In May 2019?
Article By: SureDividend Saturday, May 25, 2019 2:00 PM EDT
Volatility has returned to the stock market, as a result of escalating trade tensions. During periods of heightened geopolitical risk, it is a good time for investors to refocus on high-quality dividend growth stocks.
In this article: ABBV Also: ABT
Read
The 8 Best Dividend Stocks In May 2019: What To Buy Now
Article By: SureDividend Wednesday, May 15, 2019 9:44 AM EDT
The recent spike in volatility in the stock markets means investors should refocus on quality dividend stocks.
In this article: FRT, TGT, TROW, OZK, EV, ABBV, WBA, CAT Also: AMZN
Read
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Article By: Benzinga Saturday, April 27, 2019 6:05 PM EDT
Biotech stocks staged a recovery this week after being in the red in the previous two weeks.
In this article: BTX, BOLD, REGN, BIIB, GWPH, ALDX, HRTX, IONS, ADAP, NBRV, BHVN, NVS, SNY, RHHBY, ABBV
Read
Recent Stock Purchase April 2019
Article By: Keith Park Friday, April 19, 2019 5:30 PM EDT
From late March till late April today, the stock market has been looking quite strong once again.
In this article: ABBV
Read
April 2019 Stock Considerations
Article By: Keith Park Wednesday, April 3, 2019 2:10 PM EDT
These are the stocks that seem to be on the radar of many in the DGI space as we seek to maximize potential returns with high safe yields. With that being said let’s take a look at my April stock considerations.
In this article: MO, T, ABBV
Read
15 Dividend-Paying Blue Chips To Buy For The Long Run
Video By: Option Generator Saturday, March 30, 2019 10:48 AM EDT
Shedding some light on my current covered-call and buy and hold European portfolio, as well as on the list of 15 US SWANs to buy for the long run.
In this video: ABBV Also: MO, AAPL, JNJ, MMM, PG, PM, SPG, QQQ, CMCSA, CSCO, EQIX, DIA, SPY, UNH, AVGO, MSFT, SBUX
Watch
Recent Stock Purchase March 2019
Article By: Keith Park Friday, March 29, 2019 5:13 AM EDT
As the stock market continues to move up and down seemingly on a whim and without reason, I know that I can take comfort in one thing… my continued passive income hitting my account like clockwork in a predictable and consistent basis.
In this article: MO, ABBV
Read
Undervalued Growth And Dividend Growth In Health Technology
Article By: Chuck Carnevale Wednesday, March 20, 2019 11:13 AM EDT
Although many Health Technology Sector companies have significantly outperformed the market on a long-term basis, they have significantly underperformed the market since the beginning of 2015.
In this article: ABBV, AGN, AMGN, BMY, BIIB, CELG, GILD, MYL, PFE, PRGO
Read
E Under The Spotlight: AbbVie
Article By: Ingrid Hendershot Tuesday, March 12, 2019 8:33 PM EDT
Long-term investors may want to inject AbbVie into their portfolio, a high-quality biotech firm with market-leading products, a growing new product pipeline, strong cash flows, substantial share repurchases and a healthy dividend.
In this article: ABBV
Read
Biotech Stocks Hold After Brief Sell-Off Last Week…Updates
Article By: Rod Raynovich Sunday, March 10, 2019 12:22 PM EDT
Biotech ETFs lost momentum last week but held near term support near the 20 Day moving average. Now that most companies have reported we should not expect fundamentals to create volatility.
In this article: BMY, MRK, RHHBY, IBB, REGN, CELG, GILD, VRTX, XBI, ABBV
Read
E Daily Stock Pick: AbbVie Inc
Article By: Fredrik Arnold Monday, February 25, 2019 5:17 AM EDT
ABBV's price per share closed at $80.02 Friday. A year ago its price was $121.54. Price fell $41.52 per share last year, or over 34%.
In this article: ABBV
Read
Recent Purchase – AbbVie
Article By: Dividend Diplomats Monday, February 18, 2019 12:20 PM EDT
When you think ABBV, you think Humira, and that was one of the headlining items this earnings season.
In this article: ABBV
Read
1 to 16 of 300 Posts
1 2 3 ... 19